Table 2.

Multivariate Regression Analysis Evaluating Predictors of Brachytherapy

Variable	OR	95% CI	P
Age	0.08	0.98–0.98	<.001
Race (vs non-Hispanic white)
Hispanic	0.93	0.85–1.02	.115
Non-Hispanic black	0.93	0.86–0.99	.036
Asian	1.13	0.99–1.29	.074
Other	1.12	0.91–1.39	.284
Insurance (vs private)
Uninsured	0.72	0.65–0.79	<.001
Medicaid	0.83	0.77–0.89	<.001
Medicare	0.85	0.78–0.92	<.001
Other government	1.01	0.77–1.31	.940
Charlson/Deyo score (vs 0)
1	0.94	0.87–1.02	.156
2	0.78	0.67–0.92	.003
3 or higher	0.60	0.46–0.77	<.001
Residence (vs metropolitan county)
Urban county	1.13	1.05–1.22	.002
Rural county	1.01	0.83–1.24	.886
Year of diagnosis (vs 2004)
2005	1.20	1.05–1.38	.010
2006	1.09	0.95–1.25	.213
2007	1.05	0.92–1.20	.469
2008	1.17	1.02–1.34	.023
2009	1.18	1.03–1.35	.017
2010	1.20	1.05–1.37	.006
2011	1.63	1.42–1.89	<.001
2012	1.60	1.40–1.83	<.001
2013	1.69	1.48–1.93	<.001
2014	1.47	1.29–1.68	<.001
2015	1.34	1.18–1.53	<.001
Treatment facility location (vs Pacific)
New England	1.42	1.21–1.67	<.001
Middle Atlantic	1.57	1.41–1.73	<.001
South Atlantic	1.33	1.20–1.47	<.001
East North central	1.40	1.26–1.56	<.001
East South central	1.09	0.96–1.23	.171
West North central	1.58	1.38–1.81	<.001
West South central	0.89	0.79–0.99	.035
Mountain	1.03	0.88–1.21	.067
FIGO clinical stage (vs IB2)
II	0.90	0.82–1.00	.050
III	0.53	0.48–0.60	<.001
IVA	0.20	0.17–0.23	<.001

OR, odds ratio; FIGO, International Federation of Gynecology and Obstetrics.

High school completion and median household income were not included in this multivariate analysis.